SCHEMBL19243282

SCHEMBL19243282

Cn1cncc1/C=C(\C=O)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 1/20 0.38
IDO1 P14902 3/20 0.36
ALDH1A1 P00352 4/20 0.34
TDP1 Q9NUW8 3/20 0.34
MAPK1 P28482 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 1/20 0.33
LDLR P01130 1/20 0.33
PCSK9 Q8NBP7 1/20 0.33
GABRA5 P31644 1/20 0.33
GRM5 P41594 1/20 0.32
BRD9 Q9H8M2 1/20 0.32
TSHR P16473 1/20 0.32
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NQO2 P16083 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19209134 0.83 NPC1 (0.42) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL19209133 0.83 NPC1 (0.42) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL19209059 0.77 CYP11B1 (0.33) ALDH1A1TDP1MAPK1CYP11B2
SCHEMBL19209058 0.77 CYP11B1 (0.33) ALDH1A1TDP1MAPK1CYP11B2
SCHEMBL2219288 0.69 TBXAS1 (0.45)
SCHEMBL52612 0.68
SCHEMBL6208774 0.67 CYP11B1 (0.46) HPGDSIDO1ALDH1A1MEN1KMT2A
SCHEMBL7995907 0.67 ALDH1A1 (0.54) ALDH1A1TDP1MAPK1MEN1KMT2A
SCHEMBL566814 0.67 ALDH1A1 (0.54) ALDH1A1TDP1MAPK1MEN1KMT2A
SCHEMBL566813 0.67 ALDH1A1 (0.54) ALDH1A1TDP1MAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017134555-A1 DERIVATIVES OF PYRROLOIMIDAZOLE OR ANALOGUES THEREOF WHICH ARE USEFUL FOR THE TREATMENT OF INTER ALIA CANCER EMCURE PHARMACEUTICALS LIMITED (IN) 2017-08-10 WO disclosed